Advertisement

Renal Cell and Renal Pelvis/Ureter Carcinoma

  • Declan O’RourkeEmail author
Chapter
  • 41 Downloads

Abstract

Renal Cell and Renal Pelvis/Ureter Carcinoma: this chapter outlines the incidence, risk factors, clinical presentation, investigations, treatments and prognosis of cancer at this anatomical site. These features are correlated with the core data that are required to make corresponding histopathology reports of a consistently high quality, available in an appropriate timeframe, and clinically relevant to patient management and prognosis. Summary details of the common cancers given at this site include: gross description, histological types, tumour grade/differentiation, extent of local tumour spread, lymphovascular invasion, lymph node involvement, and the status of excision margins. Current WHO Classifications of Malignant Tumours and TNM8 are referenced. Notes are provided on other associated pathology, contemporary use of immunohistochemistry, updates on the role of evolving molecular tests, and the use of these ancillary techniques as biomarkers in diagnosis, and prediction of prognosis and treatment response. A summary is given of the more common non-carcinoma malignancies that are encountered at this site in diagnostic practice.

Keywords

Renal cell carcinoma Urothelial carcinoma TNM8 Clear cell carcinoma Papillary renal cell carcinoma Chromophobe Sarcomatoid change 

References

  1. Algaba F, Delahunt B, Berney DM, Camparo P, Comperat E, Griffiths DF, et al. Handling and reporting of nephrectomy specimens for adult renal tumours: a survey by the European network of uropathology. J Clin Pathol. 2012;65:106–13.CrossRefGoogle Scholar
  2. Allen DC, Cameron RI. Histopathology specimens: clinical, pathological and laboratory aspects. 3rd ed. London: Springer; 2017.CrossRefGoogle Scholar
  3. Amin M, Epstein J, Ulbright T, Humphrey P, Egevad L, Montironi R, et al. Best practices recommendations in the application of immunohistochemistry in urologic pathology: report from the International Society of Urological Pathology consensus conference. Am J Surg Pathol. 2014;38:1017–22.CrossRefGoogle Scholar
  4. Amin MB, Edge SB, Greene FL, Byrd DR, Brookland RK, Washington MK, et al. American Joint Cancer Committee cancer staging manual. 8th ed. Switzerland: Springer International; 2017.Google Scholar
  5. Association of Directors of Anatomic and Surgical Pathology. Recommendations for the reporting of surgically resected specimens of renal cell carcinoma. Am J Clin Pathol. 2009;131:623–30.CrossRefGoogle Scholar
  6. Bonsib SM. Macroscopic assessment, dissection protocols and histologic sampling strategy for renal cell carcinomas. Diagn Histopathol. 2008;14:151–6.CrossRefGoogle Scholar
  7. Brierley JD, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours. 8th ed. Oxford: Wiley-Blackwell; 2017a.Google Scholar
  8. Brierley JD, Gospodarowicz MK, Wittekind C. Renal pelvis and ureter; urinary bladder; urethra. In: Brierley JD, Gospodarowicz MK, Wittekind C, editors. TNM classification of malignant tumours. 8th ed. Oxford: Wiley-Blackwell; 2017b.Google Scholar
  9. Carvalho JC, Thomas DG, McHugh JB, Shah RB, Kunju LP. p63, CK7, PAX8 and INI-1: an optimal immunohistochemical panel to distinguish poorly differentiated urothelial cell carcinoma from high-grade tumours of the renal collecting system. Histopathology. 2012;60:597–608.CrossRefGoogle Scholar
  10. Delahunt B, Cheville JC, Martignoni G, Humphrey PA, Magi-Galluzzi C, McKenney J, et al. The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters. Am J Surg Pathol. 2013a;37:1490–504.CrossRefGoogle Scholar
  11. Delahunt B, Egevad L, Montironi R, Srigley JR. International Society of Urological Pathology (ISUP) consensus conference on renal neoplasia: rationale and organization. Am J Surg Pathol. 2013b;37:1463–8.CrossRefGoogle Scholar
  12. Delahunt B, Srigley J, Amin M, Billis A, Camparo P, Evans A, et al. Renal biopsy for tumour, histopathology reporting guide. 1st ed. Sydney: International Collaboration on Cancer Reporting; 2017.Google Scholar
  13. Delahunt B, Srigley JR, Montironi R, Egevad L. Advances in renal neoplasia.Google Scholar
  14. Eble JN, Sauter G, Epstein JI, Sesterhenn IA. WHO classification of tumours. Pathology and genetics. Tumours of the urinary system and male genital organs. Lyon: IARC Press; 2004.Google Scholar
  15. Fleming S, Griffiths DFR. Nephrectomy for renal tumour; dissection guide and dataset. ACP best practice no 180. J Clin Pathol. 2005;58:7–14.CrossRefGoogle Scholar
  16. Griffiths DFR, Vujanic GM. Cystic lesions of the kidney-selected topics. Curr Diagn Pathol. 2002;8:94–101.CrossRefGoogle Scholar
  17. Griffiths DFR, Nind N, O’Brien CJ, Rashid M, Verghese A. Evaluation of a protocol for examining nephrectomy specimens with renal cell carcinoma. J Clin Pathol. 2003;56:374–7.CrossRefGoogle Scholar
  18. IARC, WHO Classification of Tumours. Urinary system and male genital organs. 4th ed. Lyon: WHO/IARC Press; 2016.Google Scholar
  19. Kluzek K, Bluyssen H, Wesoly J. The epigenetic landscape of clear-cell renal cell carcinoma. J Kidney Cancer VHL. 2015;2:90–104.CrossRefGoogle Scholar
  20. Kuroda N, Tanaka A, Yamaguchi T, et al. Chromophobe renal cell carcinoma, oncocytic variant: a proposal of a new variant giving a critical diagnostic pitfall in diagnosing renal oncocytic tumors. Med Mol Morphol. 2013;46:49e55.CrossRefGoogle Scholar
  21. Mathers C, Pollock AM, Marsh C, O’Donnell M. Cytokeratin 7: a useful adjunct in the diagnosis of chromophobe renal cell carcinoma. Histopathology. 2002;40:563–7.CrossRefGoogle Scholar
  22. Olgae S, Mazumdar M, Dalbagni G, Reuter VE. Urothelial carcinoma of the renal pelvis. A clinicopathologic study of 130 cases. Am J Surg Pathol. 2004;28:1545–52.CrossRefGoogle Scholar
  23. Perez-Montiel D, Suster S. Upper urinary tract carcinomas: histological types and unusual morphological variants. Diagn Histopathol. 2007;14:48–54.CrossRefGoogle Scholar
  24. Sebire NJ, Vujanic VM. Paediatric renal tumours: recent developments, new entities and pathological features. Histopathology. 2009;54:516–28.CrossRefGoogle Scholar
  25. Shah RB, Bakshi N, Hafez K, Wood DP, Kunju LP. Image-guided biopsy in the evaluation of renal mass lesions in contemporary urological practice: indications, adequacy, clinical impact and limitations of the pathological diagnosis. Hum Pathol. 2005;36:1309–15.PubMedGoogle Scholar
  26. Shanks J, Chandra A, McWilliam L, Varma M. Dataset for tumours of the urinary collecting system (renal pelvis, ureter, urinary bladder and urethra). 2nd ed. London: The Royal College of Pathologists; 2013.Google Scholar
  27. Srigley JR, Delahunt B, Eble JN, et al. The International Society of Urological Pathology (ISUP) Vancouver classification of renal neoplasia. Am J Surg Pathol. 2013;37:1469e89.CrossRefGoogle Scholar
  28. Tavora F, Fajardo DA, Lee TK, Lotan T, Miller JS, Miyamoto H, Epstein JI. Small endoscopic biopsies in the ureter and renal pelvis: pathologic pitfalls. Am J Surg Pathol. 2009;33:1540–6.CrossRefGoogle Scholar
  29. The Royal College of Pathologists. Cancer datasets (adult renal parenchymal cancer, renal tumours in childhood, penile cancer, prostatic carcinoma, testicular tumours and post-chemotherapy residual masses, tumours of the urinary collecting system) and tissue pathways (medical renal biopsies, urological pathology). 2015. https://www.rcpath.org/profession/guidelines/cancer-datasets-and-tissue-pathways.html.
  30. Tickoo SK, de Peralta-Venturina MN, Harik LR, Worcester HD, Salama ME, Young AN, Moch H, Amin MB. Spectrum of epithelial neoplasms in end-stage renal disease. Am J Surg Pathol. 2006;30:141–53.CrossRefGoogle Scholar
  31. Trpkov K, Hes O. New and emerging renal entities: a perspective post-WHO 2016 classification. Histopathology. 2019;74:31–59.CrossRefGoogle Scholar
  32. Trpkov K, Yilmaz A, Uzer D, Dishongh KM, Quick CM, Bismar TA, Gokden N. Renal oncocytoma revisited: a clinicopathological study of 109 cases with emphasis on problematic diagnostic features. Histopathology. 2010;57:892–906.CrossRefGoogle Scholar
  33. Vasudev N, Banks R. Biomarkers of renal cancer. In: Edelstein CL, editor. Biomarkers of kidney disease. 2nd ed. Cambridge: Academic; 2016.Google Scholar
  34. Veeratterapillay R, Simren R, El-Sherif A, Johnson MI, Soomro N, Heer R. Accuracy of the revised 2010 TNM classification in predicting the prognosis of patients treated for renal cell cancer in the north east of England. J Clin Pathol. 2012;65:367–71.CrossRefGoogle Scholar
  35. Venturina MD-P, Moch H, Amin M, Tamboli P, Hailemarian S, Mitatsch M, Javidan J, Stricker H, Ro JY, Amin MB. Sarcomatoid differentiation in renal cell carcinoma. A study of 101 cases. Am J Surg Pathol. 2001;25:275–84.CrossRefGoogle Scholar
  36. Weinstock M, McDermott D. Targeting PD-1/PD-L1 in the treatment of metastatic renal cell carcinoma. Ther Adv Urol. 2015;7:365–77.CrossRefGoogle Scholar
  37. Williamson SR, Taneja K, Cheng L. Renal cell carcinoma staging: pitfalls, challenges, and updates. Histopathology. 2019;74:18–30.CrossRefGoogle Scholar
  38. Zhang PL, Kanaan H. Silva’s diagnostic renal pathology. 2nd ed. Cambridge: Cambridge University Press; 2017.Google Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Institute of PathologyRoyal Victoria HospitalBelfastUK

Personalised recommendations